Harlan S Robins's Net Worth
$38.9 Million
Who is Harlan S Robins?
Harlan S Robins has an estimated net worth of $38.9 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, and CM Life Sciences III Inc..
SEC CIK
Harlan S Robins's CIK is 0001780851
Past Insider Trading and Trends
2021 was Harlan S Robins's most active year for acquiring shares with 41 total transactions. Harlan S Robins's most active month to acquire stocks was the month of February. 2021 was Harlan S Robins's most active year for disposing of shares, totalling 117 transactions. Harlan S Robins's most active month to dispose stocks was the month of December. 2021 saw Harlan S Robins paying a total of $2,469,681.60 for 626,964 shares, this is the most they've acquired in one year. In 2021 Harlan S Robins cashed out on 772,460 shares for a total of $21,630,626.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
Chief Scientific OfficerHarlan S Robins owns 1,021,180 units of Common Stock which is worth $4,299,167.80. From 2022 to 2024 Harlan S Robins acquired a total of 1,848,577 shares in Adaptive Biotechnologies Corp at a cost of $4,784,697.60, Harlan also disposed a total of 826,697 shares of Adaptive Biotechnologies Corp equalling to $39,370,023.82.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.20% | 354.61K |
—
|
—
| 1.02M |
Mar 4
| |||
Form 4
| +113.67% | 354.61K |
—
|
—
| 666.57K |
Mar 6
| |||
Form 4
| +349.77% | 242.6K |
$12.01 | -$54,249.17 | 311.96K |
Mar 4 - Mar 7
| |||
Form 4
|
—
|
0
|
$19.27 | -$101,793.00 | 69.36K |
Scheduled
|
Nov 17 - Nov 18
| ||
Form 4
|
—
|
0
|
$20.13 | -$304,201.00 | 69.36K |
Scheduled
|
Oct 19 - Oct 21
| ||
Form 4
|
—
|
0
|
$19.64 | -$311,169.25 | 69.36K |
Scheduled
|
Oct 6 - Oct 8
| ||
Form 4
|
—
|
0
|
$21.65 | -$358,204.80 | 69.36K |
Scheduled
|
Sep 13 - Sep 15
| ||
Form 4
|
—
|
0
|
$20.29 | -$326,381.86 | 69.36K |
Scheduled
|
Aug 25 - Aug 27
| ||
Form 4
|
—
|
0
|
$21.90 | -$364,035.51 | 69.36K |
Scheduled
|
Jul 19 - Jul 21
| ||
Form 4/A
|
—
|
0
|
$20.94 | -$227,815.39 | 69.36K |
Scheduled
|
May 5 - May 6
| ||
Form 4
|
—
|
0
|
$21.82 | -$362,215.85 | 69.36K |
Scheduled
|
Jun 9 - Jun 11
| ||
Form 4
| +0.49% | 700 |
$20.95 | -$203,014.39 | 142.62K |
Scheduled
|
May 5 - May 6
| ||
Form 4
|
—
|
0
|
$21.23 | -$116,131.65 | 69.36K |
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
$23.94 | -$960,896.80 | 69.36K |
Scheduled
|
Apr 20 - Apr 22
| ||
Form 4
|
—
|
0
|
$23.34 | -$662,978.54 | 69.36K |
Scheduled
|
Mar 23 - Mar 25
| ||
Form 4
| +10,115.02% | 68.68K |
—
|
—
| 69.36K |
Mar 4
| |||
Form 4
|
—
|
0
|
$32.95 | -$414,925.30 | 679 |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$32.03 | -$801,136.03 | 679 |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
|
—
|
0
|
$36.57 | -$1,413,893.16 | 679 |
Scheduled
|
Jan 21
| ||
Form 4/A
|
—
|
0
|
$37.07 | -$6,104,576.07 | 679 |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
|
—
|
0
|
$36.96 | -$6,127,576.07 | 679 |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
|
—
|
0
|
$28.51 | -$1,477,791.48 | 679 |
Scheduled
|
Nov 4 - Nov 6
| ||
Form 4
|
—
|
0
|
$29.06 | -$504,717.00 | 679 |
Scheduled
|
Oct 16
| ||
Form 4
|
—
|
0
|
$29.09 | -$1,011,033.60 | 679 |
Scheduled
|
Oct 14 - Oct 15
| ||
Form 4
|
—
|
0
|
$26.97 | -$1,374,973.80 | 679 |
Scheduled
|
Sep 22 - Sep 24
| ||
Form 4
|
—
|
0
|
$24.58 | -$1,216,241.60 | 679 |
Scheduled
|
Aug 19 - Aug 21
| ||
Form 4
|
—
|
0
|
$22.95 | -$1,107,524.06 | 679 |
Scheduled
|
Jul 16 - Jul 17
| ||
Form 4
|
—
|
0
|
$26.43 | -$1,339,356.81 | 679 |
Scheduled
|
Jun 23 - Jun 25
| ||
Form 4
| -99.04% | -70.00K |
$40.28 | -$2,819,307.64 | 679 |
Scheduled
|
May 19 - May 20
| ||
Form 4
|
—
|
0
|
$21.59 | -$2,372,300.64 | 70.68K |
Scheduled
|
May 14 - May 18
| ||
Form 4
|
—
|
0
|
$18.01 | -$1,037,907.75 | 70.68K |
Scheduled
|
Apr 20 - Apr 22
| ||
Form 4
|
—
|
0
|
$19.89 | -$200,810.00 | 70.68K |
Scheduled
|
Feb 20
| ||
Form 4
|
—
|
0
|
$19.04 | -$658,991.00 | 70.68K |
Scheduled
|
Feb 18 - Feb 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
$17.55 | -$249,177.00 | 70.68K |
Scheduled
|
Jan 15 - Jan 17
| ||
Form 4
|
∞
| 70.68K |
—
|
—
| 70.68K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CM Life Sciences III Inc. (EQRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||